Previous close | 1,059.42 |
Open | 1,069.51 |
Bid | 1,061.80 x 3200 |
Ask | 1,061.55 x 900 |
Day's range | 1,041.88 - 1,066.03 |
52-week range | 579.40 - 1,271.67 |
Volume | 242,953 |
Avg. volume | 126,759 |
Market cap | 24.826B |
Beta (5Y monthly) | 1.00 |
PE ratio (TTM) | 42.58 |
EPS (TTM) | 24.91 |
Earnings date | 05 May 2021 - 10 May 2021 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 1,182.18 |
Mettler-Toledo (MTD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Columbus, OH, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) today announced the webcast of its presentation at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference on Wednesday, February 24, 2021, at 10:45 a.m Eastern Time. To hear a live webcast of the presentation, visit the investor relations page on the Company’s Web site at www.mt.com/investors. A replay of the webcast will be available for seven days. METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com. CONTACT: Mary T. Finnegan Investor Relations +1-614-438-4748
Mettler-Toledo's (MTD) fourth-quarter 2020 results reflect benefits from the well-performing Laboratory and Food Retail product lines amid the coronavirus-led headwinds.